By Theo Vermeire, Head of Department Nanotechnology, Occupational Health and Transport Safety Centre for Safety of Substances and Products, National Institute for Public Health and the Environment (RIVM) – The Netherlands
SCENIHR, SCHER and SCCS Opinions on Synthetic Biology
Synthetic biology (SynBio) has already delivered important products to the market such as yeast-synthesized artemisinin and biodegradable plastics produced from sugars. There is a potential for substantial contributions to medicine, materials, chemistry, food, nutrition, energy, sustainability, waste treatment, and safety. Yet, like for many new and emerging technologies, there is controversy leading to fierce debates on SynBio’s potential for societal benefit, or risks.
Health-EU newsletter 144 - Focus